• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Vaccination Cuts Risk of Severe COVID-19 in Patients on Dialysis
WEDNESDAY, June 1, 2022 -- For patients receiving hemodialysis who become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), prior SARS-CoV-2 vaccination is associated with reduced risk of severe COVID-19, according to a...
Source: Drugs.com - Pharma News - June 1, 2022 Category: Pharmaceuticals Source Type: news

Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
WEDNESDAY, Feb. 16, 2022 -- For patients undergoing hemodialysis, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA-1273 vaccine elicits a stronger humoral response than the BNT162b2 vaccine, according to a study published online...
Source: Drugs.com - Pharma News - February 16, 2022 Category: Pharmaceuticals Source Type: news

Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients
WEDNESDAY, Dec. 15, 2021 -- For persons receiving dialysis, the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wanes through five to six months and is associated with a risk for breakthrough infection, according to...
Source: Drugs.com - Pharma News - December 15, 2021 Category: Pharmaceuticals Source Type: news

Hemodialysis Patients Have Antibody Response to COVID-19 Vaccine
FRIDAY, June 11, 2021 -- Most hemodialysis patients (HDP) but few kidney transplant recipients (KTRs) develop antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after receipt of an mRNA vaccine, according to a study...
Source: Drugs.com - Pharma News - June 11, 2021 Category: Pharmaceuticals Source Type: news

One Dose of BNT162b2 Inadequate for Hemodialysis Patients
THURSDAY, May 27, 2021 -- For a majority of hemodialysis patients, a single dose of the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine fails to elicit a humoral response, according to a study published online May 12 in...
Source: Drugs.com - Pharma News - May 27, 2021 Category: Pharmaceuticals Source Type: news

Dialysis Patients Maintain Humoral Response to SARS-CoV-2 Infection
WEDNESDAY, May 26, 2021 -- Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositive patients receiving dialysis maintain receptor-binding domain (RBD) immunoglobulin G (IgG) levels over a period of six months, according to a...
Source: Drugs.com - Pharma News - May 26, 2021 Category: Pharmaceuticals Source Type: news